Boiron S.A. is a leading pharmaceutical enterprise focused on the global development and sale of homeopathic treatments. Its market presence extends across France, the wider European continent, North America, and numerous international territories. The company's offerings comprise a diverse array of homeopathic products, including both non-proprietary and branded formulations. Notable examples from its brand portfolio target specific health concerns: Oscillococcinum is formulated to alleviate symptoms associated with influenza, such as fever, chills, headaches, and general body aches. Stodal and Stodaline are designed for the symptomatic relief of coughs. Arnigel provides topical support for minor, non-open traumatic injuries. Camilia is specifically developed to soothe teething discomfort in infants. Sédatif PC addresses anxiety, emotional imbalances, and mild sleep disturbances. Coryzalia helps manage cold symptoms and rhinitis. Homéoptic offers relief for various types of eye irritation and discomfort in both adults and children. Homéovox is aimed at vocal disorders. Beyond its core homeopathic line, Boiron provides a range of supplementary health products. These include dietary supplements; the Dermoplasmine collection (available as stick, balm, and mousse) for dry lips and skin; Mag' Nuit, designed to aid sleep; Arnitrosium for joint pain; Castor Equi Boiron ointment to treat cracked skin; and Storinil, a syrup for cold treatment. Furthermore, the company produces herbal medicines, such as Canephron, which supports increased urine production and improved urinary elimination. Its product list also features moisturizing baby milk and a selection of medical devices, including COVID-19 self-tests and rapid antigenic tests. Boiron distributes its extensive product portfolio through a wide network, encompassing its own distribution centers, independent pharmacies, large pharmacy chains, wholesalers, grocery stores, specialized health food retailers, and online sales platforms. Established in 1932, Boiron S.A. maintains its corporate headquarters in Messimy, France.
The current price of BOIRF is $31.50 USD — it has increased by +0% in the past 24 hours. Watch Boiron stock price performance more closely on the chart.
What is Boiron stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Boiron stocks are traded under the ticker BOIRF.
What is Boiron market cap?▼
Today Boiron has the market capitalization of 552.67M
What is Boiron revenue for the last year?▼
Boiron revenue for the last year amounts to 589.28M USD.
What is Boiron net income for the last year?▼
BOIRF net income for the last year is 38.36M USD.
Does Boiron pay dividends?▼
Yes, BOIRF dividends are paid annual. The last dividend per share was 1.56 USD. As of today, Dividend Yield (FWD)% is 4.94%.
How many employees does Boiron have?▼
As of July 29, 2026, the company has 2,469 employees.